Trial Details

COMPLETED
Basic Information
Clinical ID c3734
Identifier NCT01611805
Trial Title Japanese Phase I of GSK1605786
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: GSK1605786|DRUG: GSK1605786 Placebo
Participant Information
Sponsor GlaxoSmithKline
City New South Wales
Country/Region Australia
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2010-07-22
Primary Completion Date 2010-10-06
Completion Date 2010-10-06